文献速递妇产影像泌尿生殖MR

基于瘤内及瘤周MRI影像组学列线图预测早期宫颈腺癌及腺鳞癌宫旁浸润

Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma.
PubMed 文献 · Eur Radiol · 2023-08-23

回顾性纳入460例IB-IIB期宫颈腺癌及腺鳞癌患者,提取肿瘤及3mm、5mm瘤周环的原始和小波特征构建影像组学标签,结合FIGO分期、MRI宫颈间质环中断、MRI宫旁浸润及血清CA-125建立列线图,外部验证预测宫旁浸润AUC为0.966(0.887-0.995)。

要点

  • 列线图整合独立危险因素、基于原始-小波特征肿瘤影像组学标签和5mm瘤周影像组学标签。
  • 外部验证队列预测宫旁浸润AUC为0.966(0.887-0.995)。
  • 列线图在三个队列中均优于影像组学标签和临床模型。

核心结论

  • 列线图可术前、准确、无创地预测早期宫颈腺癌及腺鳞癌患者的宫旁浸润。

研究设计与样本

  • 回顾性纳入460例IB-IIB期宫颈腺癌及腺鳞癌患者,分为原发、内部验证和外部验证队列,术前MRI提取肿瘤及3mm、5mm瘤周环的原始和小波特征。

关键影像表现/征象

  • MRI上宫颈间质环中断(DCSRMR)被识别为宫旁浸润的独立危险因素。
  • MRI上宫旁浸润(PMIMR)被识别为宫旁浸润的独立危险因素。

诊断标准与关键数值

  • 列线图预测宫旁浸润在原发队列AUC为0.874(0.810-0.922)。
  • 列线图预测宫旁浸润在内部验证队列AUC为0.885(0.834-0.924)。
  • 列线图预测宫旁浸润在外部验证队列AUC为0.966(0.887-0.995)。
  • FIGO分期、MRI宫颈间质环中断、MRI宫旁浸润和血清CA-125被识别为独立危险因素。

临床应用与阅片要点

  • 列线图可术前、准确、无创地预测宫旁浸润,有助于在放化疗或根治性子宫切除术之间做出精确治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop a comprehensive nomogram based on MRI intra- and peritumoral radiomics signatures and independent risk factors for predicting parametrial invasion (PMI) in patients with early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC).

METHODS: A total of 460 patients with IB to IIB cervical AC and ASC who underwent preoperative MRI examination and radical trachelectomy/hysterectomy were retrospectively enrolled and divided into primary, internal validation, and external validation cohorts. The original (Ori) and wavelet (Wav)-transform features were extracted from the volumetric region of interest of the tumour (ROI-T) and 3mm- and 5mm-peritumoral rings (ROI-3 and ROI-5), respectively. Then the Ori and Ori-Wav feature-based radiomics signatures from the tumour (RST) and 3 mm- and 5 mm-peritumoral regions (RS3 and RS5) were independently built and their diagnostic performances were compared to select the optimal ones. Finally, the nomogram was developed by integrating optimal intra- and peritumoral signatures and clinical independent risk factors based on multivariable logistic regression analysis.

RESULTS: FIGO stage, disruption of the cervical stromal ring on MRI (DCSRMR), parametrial invasion on MRI (PMIMR), and serum CA-125 were identified as independent risk factors. The nomogram constructed by integrating independent risk factors, Ori-Wav feature-based RST, and RS5 yielded AUCs of 0.874 (0.810-0.922), 0.885 (0.834-0.924), and 0.966 (0.887-0.995) for predicting PMI in the primary, internal and external validation cohorts, respectively. Furthermore, the nomogram was superior to radiomics signatures and clinical model for predicting PMI in three cohorts.

CONCLUSION: The nomogram can preoperatively, accurately, and noninvasively predict PMI in patients with early-stage cervical AC and ASC.

CLINICAL RELEVANCE STATEMENT: The nomogram can preoperatively, accurately, and noninvasively predict PMI and facilitate precise treatment decisions regarding chemoradiotherapy or radical hysterectomy in patients with early-stage cervical AC and ASC.

KEY POINTS: The accurate preoperative prediction of PMI in early-stage cervical AC and ASC can facilitate precise treatment decisions regarding chemoradiotherapy or radical hysterectomy. The nomogram integrating independent risk factors, Ori-Wav feature-based RST, and RS5 can preoperatively, accurately, and noninvasively predict PMI in early-stage cervical AC and ASC. The nomogram was superior to radiomics signatures and clinical model for predicting PMI in early-stage cervical AC and ASC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Xiao ML, Fu L, Wei Y, et al. Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma. Eur Radiol. 2023. PMID: 37610442. doi:10.1007/s00330-023-10042-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。